A Study of Zelavespib (PU-H71) in Subjects With AP-MPN or BP-MPN

NCT05612633 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Samus Therapeutics Closure

Conditions

Accelerated Phase MPN
Blast Phase MPN

Interventions

DRUG: zelavespib

Sponsor

Samus Therapeutics, Inc.